Company
Latigo Biotherapeutics, Inc.
LTGO · CIK 0002056611
Acquisition (code C) of 494,800 shares; price not stated (see filing).
Reporting Person Sanofi · Transaction Code C
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001193125-26-345826 · filed 2026-08-12 · View filing →
Acquisition (code C) of 177,978 shares; price not stated (see filing).
Reporting Person Sanofi · Transaction Code C
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001193125-26-345826 · filed 2026-08-12 · View filing →
Acquisition (code C) of 4,975,543 shares; price not stated (see filing).
Reporting Persons 5AM Ventures VI, L.P. · 5AM Partners VI, LLC · 5AM Opportunities II, L.P. · 5AM Opportunities II (GP), LLC · PARMAR KUSH · Schwab Andrew J. · Transaction Code C
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001231919-26-000869 · filed 2026-08-12 · View filing →
Acquisition (code C) of 2,350,419 shares; price not stated (see filing).
Reporting Persons 5AM Ventures VI, L.P. · 5AM Partners VI, LLC · 5AM Opportunities II, L.P. · 5AM Opportunities II (GP), LLC · PARMAR KUSH · Schwab Andrew J. · Transaction Code C
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001231919-26-000869 · filed 2026-08-12 · View filing →